Letters
Antihistamines for anaphylaxis?
Primary outcome measures
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3368 (Published 18 August 2009) Cite this as: BMJ 2009;339:b3368
- Simon G A Brown, professor, emergency medicine1
- 1Royal Perth Hospital, University of Western Australia, Perth, WA 6000, Australia
- simon.brown{at}uwa.edu.au
Andreae and Andreae recommend that future trials of antihistamines in anaphylaxis should use a primary outcome of “whether antihistamines result in reduced mortality.”1
Given that death …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.